Clinical trial
Amyloidosis TTR Flow Reserve Evaluation
NCT05103943 is registered in ClinicalTrials.gov with Centre Hospitalier Régional d'Orléans as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Amyloidosis TTR Flow Reserve Evaluation
- Lead sponsor
- Centre Hospitalier Régional d'Orléans
- Phase
- Not applicable
- Overall status
- Active, not recruiting
- Start date
- February 24, 2022
- Completion date
- December 11, 2026
- Enrollment
- 50 (estimated)
- Sites
- 4
Conditions
As the registry lists them; a condition with its own page is linked.
amyloid cardiomyopathy